GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Fredun Pharmaceuticals Ltd

Fredun Pharmaceuticals Board Approved Q1 FY27 Un-Audited Financial Results

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 05 Aug 2026, 11:38 AM IST  ·  BSE ID: d6ddf948-1ca9-4865-b124-c4a6a6ac7204
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board reviewed and approved its financial performance for the first quarter of the fiscal year.
🤖 AI Summary
  • Fredun Pharmaceuticals Board approved Un-Audited Financial Results for the quarter ended 30th June, 2026.
  • Results were adopted in compliance with Regulations 30 and 33 of SEBI (LODR) Regulations, 2015.
  • A Limited Review Report from M/s. R.H. Nisar & Co, Statutory Auditor, accompanied the results.
  • The trading window for company insiders closed on July 01, 2026, and will reopen 48 hours after this declaration.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this filing.
👤
Who Is Affected
All shareholders are informed of the completion of the board's review and approval process for the quarter's financial results.
🔍
Management Signal
Management confirmed adherence to regulatory disclosure timelines by approving and filing the un-audited quarterly results.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Wait for detailed financial results to be made publicly available.
Review the Limited Review Report from the statutory auditor.
Monitor future announcements for operational or strategic updates.
LOW RISK This filing is a routine disclosure of board meeting outcomes, confirming results approval without specific financial data.
💡 Investor Takeaway
The Board of Fredun Pharmaceuticals Ltd approved the Un-Audited Financial Results for the quarter ended 30th June, 2026, in a meeting held on August 05, 2026. Specific financial figures for the period were not disclosed within this filing.
❓ Frequently Asked Questions
What was the key outcome of Fredun Pharmaceuticals' Board Meeting on August 05, 2026?
The Board of Directors considered, adopted, and approved the Un-Audited Financial Results for the quarter ended 30th June, 2026.
Which regulations did Fredun Pharmaceuticals comply with for this filing?
Fredun Pharmaceuticals complied with Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Who reviewed the financial results for Fredun Pharmaceuticals for Q1 FY27?
The Un-Audited Financial Results for the quarter ended 30th June, 2026, included a Limited Review Report issued by M/s. R.H. Nisar & Co, Statutory Auditor.
When did the trading window close for insiders at Fredun Pharmaceuticals?
The trading window for insiders at Fredun Pharmaceuticals closed on July 01, 2026, and will reopen 48 hours after the declaration of the board meeting outcome.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.